| AK |
actinic keratosis |
| ALA |
5-aminolevulinic acid; naturally occurring
precursor to protoprophyrin IX in the haem
biosynthetic pathway |
| ALA-S |
5-aminolevulinic acid synthase, rate-limiting
enzyme for haem synthesis |
| BCC |
basal cell carcinoma |
| BD |
bowen's disease |
| nBCC |
nodular basal cell carcinoma |
| sBCC |
superficial basal cell carcinoma |
| CR |
complete response; complete disappearance of the
treated lesion(s) |
| FD |
fluorescence diagnosis |
| Fluorescence |
luminescence that is caused by the absorption of
radiation at one wavelength followed by nearly immediate
reradiation usually at a different wavelength and that ceases
almost at once when the incident radiation stops |
| MAL |
methyl aminolevulinate |
| MAOP |
Methyl-[5-amino-4-oxopentanoat]; German term for
MAL |
| Non-CR |
non-complete response, any less than complete
disappearance of the treated lesion(s) |
| NMSC |
non-melanoma skin cancer |
| PAP |
photoactive porphyrins |
| PDD |
photodynamic detection |
| PDT |
photodynamic therapy |
| PpIX |
photoporphyrin IX; a potent natural
photosensitiser |
| ROS |
reactive oxygen species; an excited or higher
energy form of oxygen |
| SCC |
squamous cell carcinoma |